Drug reference
vaborbactam
β-Lactamase Inhibitor · β-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)
β-Lactamase Inhibitorβ-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Vaborbactam is a novel, boronic acid–based non–β-lactam β-lactamase inhibitor that provides broad inhibition of β-lactamases similar to avibactam and relebactam.
Related guidelines
Other β-Lactamase Inhibitor drugs
Ask House about vaborbactam
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team